What are the recommended eye drops for treating conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Eye Drops for Conjunctivitis

For bacterial conjunctivitis, apply broad-spectrum topical antibiotic such as bacitracin or moxifloxacin ophthalmic solution 1-3 times daily for 5-7 days, though most uncomplicated cases are self-limited and delayed prescribing is reasonable. 1, 2

Treatment Algorithm by Etiology

Bacterial Conjunctivitis

Clinical presentation: Mucopurulent discharge with eyelids matted shut upon waking, lack of itching, and no history of prior conjunctivitis strongly suggest bacterial etiology. 3, 4

First-line topical antibiotics:

  • Bacitracin ophthalmic ointment applied directly into the conjunctival sac 1-3 times daily for 5-7 days 1
  • Moxifloxacin 0.5% ophthalmic solution: one drop in affected eye 3 times daily for 7 days 2
  • Delayed antibiotic prescribing achieves similar symptom control as immediate prescribing in uncomplicated cases 4

Important caveat: Most uncomplicated bacterial conjunctivitis resolves spontaneously in 1-2 weeks without treatment. 3 Topical antibiotics primarily shorten duration and allow earlier return to work/school. 3

Special situations requiring systemic antibiotics:

  • Gonococcal conjunctivitis: Ceftriaxone 250 mg IM single dose PLUS azithromycin 1 g orally single dose 5
  • Chlamydial conjunctivitis: Azithromycin 1 g orally single dose OR doxycycline 100 mg orally twice daily for 7 days 5
  • Contact lens wearers: Always treat with antibiotics and refer to ophthalmology to evaluate for corneal ulcers 4, 6

Viral Conjunctivitis

Clinical presentation: Watery discharge, burning/gritty sensation, more common in adults. 4, 6 Adenovirus accounts for 65-90% of viral conjunctivitis cases. 7

Treatment is supportive only:

  • Preservative-free artificial tears (frequent application) 8
  • Cold compresses 5, 8
  • Topical antihistamine eye drops for symptomatic relief 5

Povidone-iodine (PVP-I) for epidemic keratoconjunctivitis:

  • PVP-I alone increases resolution of symptoms (RR 1.15) and signs (RR 3.19) during first week compared to artificial tears 7
  • PVP-I prevents development of subepithelial infiltrates within 30 days (RR 0.24) 7

Critical pitfall: Avoid topical corticosteroids in viral conjunctivitis as they can prolong adenoviral infections and worsen herpes simplex virus infections. 5

Allergic Conjunctivitis

Clinical presentation: Bilateral itching (most consistent sign), watery discharge, seasonal pattern. 3, 4

Stepwise treatment approach:

  1. First-line: Topical antihistamines with mast cell-stabilizing activity 5, 4

    • These combination agents are more effective than antihistamine/vasoconstrictor agents 5
    • Can be refrigerated for additional cooling relief upon instillation 5
  2. Adjunctive measures:

    • Preservative-free artificial tears (cooled) to dilute allergens and inflammatory mediators 5
    • Cold compresses 5
    • Avoid eye rubbing 5
  3. Severe cases: Brief course (1-2 weeks) of topical corticosteroids with low side-effect profile (fluorometholone, rimexolone, or loteprednol) 5

    • Monitor intraocular pressure and evaluate for cataract with baseline and periodic measurements 5
  4. Refractory cases: Topical cyclosporine 0.05% (at least 4 times daily) or tacrolimus 5

Important caveat: Oral antihistamines may worsen symptoms by inducing or exacerbating dry eye syndrome and impairing the tear film's protective barrier. 5

Vernal Keratoconjunctivitis (Severe Allergic Subtype)

For acute exacerbations: Topical corticosteroids are usually necessary to control severe symptoms. 5

Steroid-sparing options:

  • Cyclosporine 0.1% (FDA-approved for vernal keratoconjunctivitis in children and adults) 5
  • Cyclosporine 0.05% used at least 4 times daily prevents seasonal recurrences 5
  • Tacrolimus 0.03% or 0.1% (off-label) 5

Medication-Induced Conjunctivitis

Discontinue the offending agent immediately. 5, 1 Resolution occurs over weeks to months. 5

If severe inflammation present: Brief course of preservative-free topical corticosteroid ointment or cream. 5

Critical warning: Subepithelial fibrosis may continue despite stopping offending medications, particularly with chronic glaucoma medication use. 5

Red Flags Requiring Ophthalmology Referral

Refer immediately for: 1, 4

  • Visual loss
  • Moderate or severe pain
  • Severe purulent discharge
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy after 2-3 weeks
  • Recurrent episodes
  • History of herpes simplex virus eye disease
  • Immunocompromised status
  • Recent ocular surgery
  • Vesicular rash on eyelids or nose
  • Neonatal conjunctivitis

Infection Control for Viral Conjunctivitis

Patients should be counseled: 5

  • Wash hands frequently with soap and water (not sanitizer alone)
  • Use separate towels and pillows
  • Avoid close contact with others for at least 7-14 days from symptom onset
  • Healthcare workers and childcare providers must avoid work during contagious period

References

Guideline

Treatment for Left Eye Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Conjunctivitis Secondary to Welding Burns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.